A New CD38-Directed Antibody for the Treatment of Appropriate Relapsed Refractory Multiple Myeloma Patients
Virtual discusssion on A New CD38-Directed Antibody for the Treatment of Appropriate Relapsed Refractory Multiple Myeloma Patients
Speaker:
Sachin Gupta MD
Oncologist/Hematologist
California Cancer Associates for Research & Excellence (cCARE)
Virtual Meeting Info:
http://vconnect.healthstarcom.com/sgzp2p-22590/